Navigation Links
Watson First Quarter 2011 Net Revenue Increases to $877 Million
Date:4/27/2011

of assets may be negatively impacted by future events and circumstances; the timing and success of product launches; the difficulty of predicting the timing or outcome of product development efforts and FDA or other regulatory agency approvals or actions; the uncertainty associated with the identification and successful consummation of external business development transactions; market acceptance of and continued demand for Watson's products; difficulties or delays in manufacturing; the availability and pricing of third party sourced products and materials; successful compliance with FDA and other governmental regulations applicable to Watson's and its third party manufacturers' facilities, products and/or businesses; changes in the laws and regulations, including Medicare, Medicaid, and similar laws in foreign countries affecting, among other things, pricing and reimbursement of pharmaceutical products and the settlement of patent litigation; and such other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but not limited to Watson's annual report on Form 10-K for the period ended December 31, 2010. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements.  

All trademarks are the property of their respective owners.  

The following table presents Watson's results of operations for the three months ended

March 31, 2011 and 2010:

WATSON PHARMACEUTICALS, INC.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(Unaudited; in millions, except per share amounts)Three Months EndedMarch 31,20112010Net revenues$
876.5$
856.5Operating expenses:Cost of sales (excludes amortization, presented below)455.6504.7Research and development74.359.5Selling, general and administrative164.8152.0Amortization56.639.0Loss on asset sales and impairments14.41.0Total operating expenses765.7756.2Operating income 1
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. New Life Agency Adds Watson to Join Walgreens on The Fertility Pharmacy Care Card for Fertility Medication
2. Watson Confirms Welchol® Patent Challenge
3. Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results
4. Watson to Host Conference Call and Webcast to Discuss First Quarter 2011 Earnings
5. Watson Announces Approval of Nulecit™, the First Generic Alternative to Ferrlecit® for the Treatment of Iron Deficiency Anemia
6. Watson Confirms Favorable Appeals Court Ruling on Generic SEASONIQUE® Patent Challenge
7. Watson Confirms OxyContin® Patent Challenge
8. Watson Confirms District Court Ruling in Generic Fentora® Patent Suit
9. Cephalon Wins FENTORA Patent Suit Against Watson
10. Watson Launches Generic Famvir®
11. Heygood, Orr & Pearson: Los Angeles Court Orders Watson Pharmaceuticals to Produce Documents, Provide Depositions in Fentanyl Patch Death Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 28, 2014  TNI BioTech, Inc. (OTCQB: TNIB) ... on the development, marketing and distribution of opioid-related ... proxy materials with the Securities and Exchange Commission ... Shareholders to be held on Thursday, September 4, ... record date for determining those shareholders eligible to ...
(Date:7/28/2014)...  ResMed (NYSE: RMD ), an innovator ... sleep-disordered breathing and other chronic respiratory conditions, has won ... against Taiwanese medical device manufacturer APEX Medical Corp. (APEX), ... 210 and 220 masks.  The judgment was entered by ... , is appealable, and applies throughout Germany.  ...
(Date:7/28/2014)...  ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ) ... second quarter and year-to-date 2014 financial results on Monday, ... financial markets. The earnings press release will be accessible ... www.anipharmaceuticals.com . Arthur S. Przybyl ... C. Arnold , Vice President and Chief Financial Officer, ...
Breaking Medicine Technology:TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results 2
... Fla., May 11, 2011 Radiation Therapy Services ... centers, today announced financial results for the first quarter ended ... quarter of 2011 were $156.5 million, an increase of 16.4% ... of 2010. The increase in revenue was principally due to ...
... May 11, 2011 Valor Medical announced today that ... for treating cerebral aneurysms. Neucrylate AN ... a microinfusion catheter into the aneurysm.  When Neucrylate AN ... it immediately changes from a liquid into a porous, ...
Cached Medicine Technology:Radiation Therapy Services Holdings, Inc. Reports First Quarter 2011 Financial Results 2Radiation Therapy Services Holdings, Inc. Reports First Quarter 2011 Financial Results 3Radiation Therapy Services Holdings, Inc. Reports First Quarter 2011 Financial Results 4Radiation Therapy Services Holdings, Inc. Reports First Quarter 2011 Financial Results 5Radiation Therapy Services Holdings, Inc. Reports First Quarter 2011 Financial Results 6Radiation Therapy Services Holdings, Inc. Reports First Quarter 2011 Financial Results 7Radiation Therapy Services Holdings, Inc. Reports First Quarter 2011 Financial Results 8Radiation Therapy Services Holdings, Inc. Reports First Quarter 2011 Financial Results 9Radiation Therapy Services Holdings, Inc. Reports First Quarter 2011 Financial Results 10Radiation Therapy Services Holdings, Inc. Reports First Quarter 2011 Financial Results 11
(Date:7/28/2014)... 2014 Quincy Bioscience, makers of the ... to announce the release of the fourth edition of ... co-founder Mark Underwood. , The Brain Health Guide is ... techniques for readers to improve memory and promote optimal ... The Brain Health Guide provides ways to help minimize ...
(Date:7/28/2014)... Randy Dotinga HealthDay ... Scientists know it takes humans just milliseconds to look at ... Now, a new study finds that certain facial features seem ... The shape and size of the mouth, for example, ... dimensions are keys to attractiveness. The study findings ...
(Date:7/28/2014)... 2014 Ticket Down is reliable ... in Dallas, TX at the Cotton Bowl. The 2014 ... USA and it is an eight team tourney. The ... including teams from La Liga, Serie A, English Premier League, ... it out on the pitch include: Manchester United, Manchester ...
(Date:7/28/2014)... Glutamine is the most abundant single amino ... conditionally essential during times when the body undergoes large ... Immune System Support. , Having a heavy work out ... with additional glutamine may be advantageous. Glutamine supplementation may ... digestion and immune system function. Stress on the body ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, ... who are at risk of contracting meningitis because of ... according to updated recommendations from the largest pediatrician group ... for the potentially deadly infection should continue for adolescents ... In its first statement on meningococcal vaccines since ...
Breaking Medicine News(10 mins):Health News:Quincy Bioscience Launches the Fourth Edition of The Brain Health Guide 2Health News:Facial Dimensions May Be Key to First Impressions 2Health News:Facial Dimensions May Be Key to First Impressions 3Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 3Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 3Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 2Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 3
... Italians, conducted by Henley Management College and the University of ... the age of 65 is significantly higher than it ... this study was to make the first step in the ... of prescribing funds. ,The research found that the ...
... University researcher is experimenting with ways to add fibre to ... our favourite snacks . ,Sajid Alavi is an ... of Agriculture. ,His expertise is in extrusion ... to pet food. ,Alavi is researching how ...
... found a strong relationship between negative mood and multiple ... London Health Sciences Centre , London, Canada, said that ... importance of couples emotional health during IVF treatment, and ... ,A reduction in the incidence of multiple pregnancies with ...
... delivery company, announced positive results from its Phase ... each containing a progestin and an estrogen . ... study, investigating the delivery of a formulation combining Nestorone ... of the combination formulation was applied to the forearm ...
... Now all those doting dads will be given some tips ... e-mails . ,The British government is hoping that ... to support parents will appeal to fathers, as it makes ... electronic organisers and instant messaging. ,Under the ...
... A tongue-tying device that effectively pulls the tongue closer to ... treating problems of snoring and sleep apnea, suggest early results ... of respiratory organs and the resulting sound due to obstructed ... soft or loud and unpleasant. It can sometimes be frustrating ...
Cached Medicine News:Health News:Now, Fibre-enriched Tasty Snacks in the Making 2Health News:Womens Mood Plays a Key Role in Infertility Treatment 2Health News:Contraceptive Spray Shows Positive Clinical Trial Result 2Health News:New Device to Treat Snoring and Sleep Apnea 2
Threaded cannula for use with Suretac® II, sterile packs, box of 10....
... Blitz Suture Retriever is for arthroscopic and open ... design eliminates complicated procedural steps. It may ... suture material and in conjunction with,anchors or screws ... small, curved needle tip permits the placement of ...
Suture retriever forceps...
Knot pusher/suture retriever...
Medicine Products: